Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
    1.
    发明授权
    Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides 有权
    制备乙酰基 - 脒基苯丙氨酰 - 环己基甘氨酰 - 吡啶并氨酰胺的方法

    公开(公告)号:US07084250B2

    公开(公告)日:2006-08-01

    申请号:US10869076

    申请日:2004-06-17

    IPC分类号: C07K5/08

    CPC分类号: C07K5/0821 C07K5/06139

    摘要: The present invention relates to a process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides of the formula I, in which the anions X are physiologically acceptable anions, and their analogs, which are effective inhibitors of the blood coagulation factor Xa and which can be used, for example, for preventing thromboses. The process according to the invention comprises the coupling of 2-[2-acetylamino-3-(4-amidinophenyl)propionylamino]-2-cyclohexylacetic acid, which is obtained from 2-[2-acetylamino-3-(4-cyanophenyl)acryloylamino]-2-cyclohexylacetic acid by asymmetric hydrogenation and conversion of the cyano group into the amidine, or a salt thereof, with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt or a salt thereof. The invention furthermore provides starting materials and intermediates for this process, processes for their preparation and acetyl-(S)-4-amidiniophenylalanyl-(S)-cyclohexylglycyl-(S)-(1-methyl-3-pyridinio)alaninamide as ditosylate salt.

    摘要翻译: 本发明涉及一种制备式I的乙酰基 - 脒基苯脒基 - 环己基甘氨酰 - 吡啶并吡喃酰胺的方法,其中阴离子X是生理上可接受的阴离子,以及它们的类似物,它们是凝血因子Xa的有效抑制剂, 可用于例如用于预防血栓形成。 根据本发明的方法包括2- [2-乙酰氨基-3-(4-脒基苯基)丙酰基氨基] -2-环己基乙酸的偶联,其由2- [2-乙酰氨基-3-(4-氰基苯基) 丙烯酰氨基] -2-环己基乙酸,通过不对称氢化,并将氰基转化为脒或其盐与3-(2-氨基-2-氨基甲酰基乙基)-1-甲基吡啶鎓盐或其盐。 本发明还提供了该方法的起始原料和中间体,其制备方法和乙酰基 - (S)-4-脒基苯基丙氨酰 - (S) - 环己基甘氨酰 - (S) - (1-甲基-3-吡啶鎓)丙烯酰胺作为二甲苯磺酸盐 。

    Process for the enzymatic separation of enantiomers of
rac-2-oxotricyclo�2.2.1.0 3,5! heptane-7-carboxylic acid and of
rac-2-oxotricyclo�2.2.1.0 3,5! heptane-7-carboxylic esters
    4.
    发明授权
    Process for the enzymatic separation of enantiomers of rac-2-oxotricyclo�2.2.1.0 3,5! heptane-7-carboxylic acid and of rac-2-oxotricyclo�2.2.1.0 3,5! heptane-7-carboxylic esters 失效
    使用来自念珠菌的脂肪酶分离外消旋-2-氧杂环己烷-2,2.0.0,3H庚烷-7-羧酸酯的方法

    公开(公告)号:US5861304A

    公开(公告)日:1999-01-19

    申请号:US932933

    申请日:1997-09-17

    摘要: Process for the resolution of rac-2-oxotricyclo�2.2.1.0.sup.3,5 !heptane-7-carboxylic acid esters using lipase from candida.Compounds of the formula I ##STR1## in which R.sup.1 has the meanings mentioned, may be obtained in isomerically pure form from enantiomer mixtures or racemic mixtures by reacting the compound of the formula I in the presence of a lipase or esterase from porcine liver, porcine pancreas, bovine pancreas or from microorganisms such as Candida, Pseudomonas, Mucor, Rhizopus and Aspergillus, or proteases from Bacillus in the presence of water and, if desired, a cosolvent and separating from one another the esters and acids present in the solution obtained.

    摘要翻译: 使用来自念珠菌的脂肪酶拆分外消旋-2-氧代三环[2.2.1.03,5]庚烷-7-羧酸酯的方法。 通过在来自猪的脂肪酶或酯酶的存在下使式I化合物与对映体混合物或外消旋混合物以异构体纯的形式获得其中R 1具有所述含义的式I的化合物(I) 肝,猪胰腺,牛胰腺或来自诸如假丝酵母属,假单胞菌属,毛霉属,根霉属和曲霉属的微生物或来自芽孢杆菌的蛋白酶,并且如果需要,共溶剂并且彼此分离存在于 溶液得到。

    METHOD FOR THE PREPARATION OF ENANTIOMER FORMS OF CIS-CONFIGURED 3-HYDROXYCYCLOHEXANE CARBOXYLIC ACID DERIVATIVES USING HYDROLASES
    7.
    发明申请
    METHOD FOR THE PREPARATION OF ENANTIOMER FORMS OF CIS-CONFIGURED 3-HYDROXYCYCLOHEXANE CARBOXYLIC ACID DERIVATIVES USING HYDROLASES 审中-公开
    使用水解制备CIS配置的3-羟基环己烷羧酸衍生物的成膜剂形式的方法

    公开(公告)号:US20070197788A1

    公开(公告)日:2007-08-23

    申请号:US11669545

    申请日:2007-01-31

    CPC分类号: C12P41/004 C12P7/00 C12P17/00

    摘要: The present invention relates to a process for preparing chiral non-racemic cis-configured cyclohexanols or cyclohexanol derivatives of the formula (I) Cis-configured hydroxyl-cyclohexane carboxylic acid derivatives of formula (I) are central building blocks or immediate precursors for the medicinally active compounds which allow a therapeutic modulation of the lipid and/or carbohydrate metabolism and are thus suitable for preventing and/or treating type II diabetes, hyperglycemia and artherosclerosis. The cis-configured hydroxyl-cyclohexane carboxylic acid derivatives of formula (I) are central building blocks or immediate precursors for the medicinally active compounds described in the prior art.

    摘要翻译: 本发明涉及制备式(I)的手性非外消旋顺式配位的环己醇或环己醇衍生物的方法。式(I)的顺式构型的羟基 - 环己烷羧酸衍生物是用于药物的中心结构单元或直接前体 允许治疗性调节脂质和/或碳水化合物代谢并因此适合于预防和/或治疗II型糖尿病,高血糖症和动脉粥样硬化的活性化合物。 式(I)的顺式构型的羟基 - 环己烷羧酸衍生物是现有技术中描述的药物活性化合物的中心构建块或立即前体。

    Unsaturatd sugar compounds
    8.
    发明授权
    Unsaturatd sugar compounds 失效
    不熟化的糖化合物

    公开(公告)号:US5496930A

    公开(公告)日:1996-03-05

    申请号:US315500

    申请日:1994-09-30

    摘要: A process for highly regioselective esterification and ester cleavage on unsaturated sugar compounds with the aid of lipases and esterases, and products which can be prepared by this process.Highly regioselective esterifications and ester cleavages can be carried out on unsaturated sugar compounds with the aid of lipases and esterases. Lipases from microorganisms or from the pancreas and liver of animals are preferably used.

    摘要翻译: 借助于脂肪酶和酯酶的不饱和糖化合物的高度区域选择性酯化和酯裂解的方法,以及可以通过该方法制备的产物。 借助于脂肪酶和酯酶,可以在不饱和糖化合物上进行高度区域选择性酯化和酯裂解。 优选使用来自微生物或来自动物的胰脏和肝脏的脂肪酶。